Matthias Renner

Matthias Renner is Head of Section “Assessment Quality of Coagulation Products and Gene Therapy“ in the Department of Hematology, Cell and Gene Therapy and Senior Scientific Assessor for quality of ATMPs at the Paul-Ehrlich-Institut (PEI), the German Federal Institute for the regulation of vaccines and biomedicines. In his work Matthias is involved in the evaluation of clinical trial applications and national scientific advice procedures for ATMPs and serves as scientific consultant in GMP-inspections of Gene Therapy Medicinal Products.

Since 2009 he is expert to the European Medicines Agency (EMA) for the assessment of marketing authorisation applications, for scientific advices and other EMA procedures. He is Member of the CHMP Biologics Working Party at EMA, of the EDQM Gene Therapy Working Group and of the Cell and Gene Therapy Committee of the International Alliance for Biological Standardization.

Before he joined the PEI, he worked in several positions in biotech industry on the development of cell and gene therapies. Matthias holds a Ph.D. and a lecturer´s degree in Virology.